Preclinical research in Rett syndrome: Setting the foundation for translational success

DMM Disease Models and Mechanisms

Volumn 5, Issue 6, 2012, Pages 733-745

  Katz, David M ^a   Berger Sweeney, Joanne E ^b   Eubanks, James H ^c   Justice, Monica J ^d   Neul, Jeffrey L ^d,e   Pozzo Miller, Lucas ^f   Blue, Mary E ^g   Christian, Diana ^a   Crawley, Jacqueline N ^h   Giustetto, Maurizio ⁱ   Guy, Jacky ^j   Howell, C James ^a   Kron, Miriam ^a   Nelson, Sacha B ^k   Samaco, Rodney C ^e   Schaevitz, Laura R ^b   Hillaire Clarke, Coryse St ^l   Young, Juan L ^m   Zoghbi, Huda Y ^e,n   Mamounas, Laura A ^l  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e TEXAS CHILDREN S HOSPITAL   (United States)

^f University of Alabama at Birmingham   (United States)

^g KENNEDY KRIEGER INSTITUTE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF TURIN   (Italy)

^j UNIVERSITY OF EDINBURGH   (United Kingdom)

^k BRANDEIS UNIVERSITY   (United States)

^l NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^m UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁿ HOWARD HUGHES MEDICAL INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ANXIETY; BREATHING DISORDER; CLINICAL FEATURE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COGNITION; CONSTRUCT VALIDITY; DISEASE MODEL; ELECTROENCEPHALOGRAM; GAIT DISORDER; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL TRACT FUNCTION; GENE; HEALTH; HOMEOSTASIS; HUMAN; KNOWLEDGE MANAGEMENT; LIFESPAN; LOCOMOTION; LOSS OF FUNCTION MUTATION; MICROCEPHALY; MUSCLE HYPOTONIA; NONHUMAN; NUTRITION; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QT PROLONGATION; REPRODUCIBILITY; RETT SYNDROME; REVIEW; SOCIAL BEHAVIOR; TRANSLATIONAL RESEARCH; TREMOR; VASOMOTOR DISORDER;

ANIMALS; CONGRESSES AS TOPIC; DISEASE MODELS, ANIMAL; GUIDELINES AS TOPIC; HUMANS; RESEARCH REPORT; RETT SYNDROME; TRANSLATIONAL MEDICAL RESEARCH;

ANIMALIA; EUNICE;

EID: 84870018625     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.011007     Document Type: Review

References (141)

1. Abdala, A. P., Dutschmann, M., Bissonnette, J. M. and Paton, J. F. (2010). Correction of respiratory disorders in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. USA 107, 18208-18213.
2. Alvarez-Saavedra, M., Sáez, M. A., Kang, D., Zoghbi, H. Y. and Young, J. I. (2007). Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis. Hum. Mol. Genet. 16, 2315-2325. (Pubitemid 47423897)
3. Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U. and Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185-188. (Pubitemid 29455390)
4. Archer, H. L., Evans, J., Edwards, S., Colley, J., Newbury-Ecob, R., O'Callaghan, F., Huyton, M., O'Regan, M., Tolmie, J., Sampson, J. et al. (2006). CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J. Med. Genet. 43, 729-734. (Pubitemid 44483915)
5. Ariani, F., Hayek, G., Rondinella, D., Artuso, R., Mencarelli, M. A., Spanhol-Rosseto, A., Pollazzon, M., Buoni, S., Spiga, O., Ricciardi, S. et al. (2008). FOXG1 is responsible for the congenital variant of Rett syndrome. Am. J. Hum. Genet. 83, 89-93.
6. Armstrong, D., Dunn, J. K., Antalffy, B. and Trivedi, R. (1995). Selective dendritic alterations in the cortex of Rett syndrome. J. Neuropathol. Exp. Neurol. 54, 195-201.
7. Armstrong, D. D. (2002). Neuropathology of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 8, 72-76.
8. Armstrong, D. D., Dunn, K. and Antalffy, B. (1998). Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J. Neuropathol. Exp. Neurol. 57, 1013-1017. (Pubitemid 28525447)
9. Asaka, Y., Jugloff, D. G., Zhang, L., Eubanks, J. H. and Fitzsimonds, R. M. (2006). Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol. Dis. 21, 217-227. (Pubitemid 41817320)
10. Baptista, P. M., Mercadante, M. T., Macedo, E. C. and Schwartzman, J. S. (2006). Cognitive performance in Rett syndrome girls: a pilot study using eyetracking technology. J. Intellect. Disabil. Res. 50, 662-666. (Pubitemid 44123258)
11. Bauman, M. L., Kemper, T. L. and Arin, D. M. (1995a). Microscopic observations of the brain in Rett syndrome. Neuropediatrics 26, 105-108.
12. Bauman, M. L., Kemper, T. L. and Arin, D. M. (1995b). Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology 45, 1581-1586.
13. Bebarta, V., Luyten, D. and Heard, K. (2003). Emergency medicine animal research: does use of randomization and blinding affect the results? Acad. Emerg. Med. 10, 684-687. (Pubitemid 36667073)
14. Begley, C. G. and Ellis, L. M. (2012). Drug development: Raise standards for preclinical cancer research. Nature 483, 531-533.
15. Belichenko, P. V., Oldfors, A., Hagberg, B. and Dahlström, A. (1994). Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 5, 1509-1513. (Pubitemid 24251884)
16. Berry-Kravis, E. M., Hessl, D., Rathmell, B., Zarevics, P., Cherubini, M., Walton-Bowen, K., Mu, Y., Nguyen, D. V., Gonzalez-Heydrich, J., Wang, P. P. et al. (2012). Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Sci. Transl. Med. 4, 152ra127.
17. Bissonnette, J. M. and Knopp, S. J. (2006). Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice. Pediatr. Res. 59, 513-518. (Pubitemid 43740048)
18. Boggio, E. M., Lonetti, G., Pizzorusso, T. and Giustetto, M. (2010). Synaptic determinants of rett syndrome. Front. Synaptic Neurosci. 2, 28.
19. Brendel, C., Belakhov, V., Werner, H., Wegener, E., Gärtner, J., Nudelman, I., Baasov, T. and Huppke, P. (2011). Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model. J. Mol. Med. (Berl.) 89, 389-398.
20. Brunner, D., Balci, F. and Ludvig, E. A. (2012). Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration. Behav. Processes 89, 187-195.
21. Calfa, G., Hablitz, J. J. and Pozzo-Miller, L. (2011a). Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging. J. Neurophysiol. 105, 1768-1784.
22. Calfa, G., Percy, A. K. and Pozzo-Miller, L. (2011b). Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp. Biol. Med. (Maywood) 236, 3-19.
23. Chang, S., Bray, S. M., Li, Z., Zarnescu, D. C., He, C., Jin, P. and Warren, S. T. (2008). Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat. Chem. Biol. 4, 256-263. (Pubitemid 351419125)
24. Chang, Q., Khare, G., Dani, V., Nelson, S. and Jaenisch, R. (2006). The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 2, 341-348. (Pubitemid 43152236)
25. Chapleau, C. A., Calfa, G. D., Lane, M. C., Albertson, A. J., Larimore, J. L., Kudo, S., Armstrong, D. L., Percy, A. K. and Pozzo-Miller, L. (2009). Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiol. Dis. 35, 219-233.
26. Chen, R. Z., Akbarian, S., Tudor, M. and Jaenisch, R. (2001). Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27, 327-331. (Pubitemid 32201857)
27. Cheval, H., Guy, J., Merusi, C., De Sousa, D., Selfridge, J. and Bird, A. (2012). Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows. Hum. Mol. Genet. 21, 3806-3814.
28. Choi, D., Stables, J. P. and Kohn, H. (1996). Synthesis and anticonvulsant activities of N-Benzyl-2-acetamidopropionamide derivatives. J. Med. Chem. 39, 1907-1916.
29. Coenraads, M. (2007). Face to face with Rett syndrome. Epigenetics 2, 2-4.
30. Cohen, S., Gabel, H. W., Hemberg, M., Hutchinson, A. N., Sadacca, L. A., Ebert, D. H., Harmin, D. A., Greenberg, R. S., Verdine, V. K., Zhou, Z. et al. (2011). Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72-85.
31. Collins, A. L., Levenson, J. M., Vilaythong, A. P., Richman, R., Armstrong, D. L., Noebels, J. L., David Sweatt, J. and Zoghbi, H. Y. (2004). Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679-2689. (Pubitemid 39485416)
32. D'Cruz, J. A., Wu, C., Zahid, T., El-Hayek, Y., Zhang, L. and Eubanks, J. H. (2010). Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice. Neurobiol. Dis. 38, 8-16.
33. Dani, V. S. and Nelson, S. B. (2009). Intact long-term potentiation but reduced connectivity between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome. J. Neurosci. 29, 11263-11270.
34. Dani, V. S., Chang, Q., Maffei, A., Turrigiano, G. G., Jaenisch, R. and Nelson, S. B. (2005). Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. USA 102, 12560-12565. (Pubitemid 41266398)
35. De Filippis, B., Ricceri, L. and Laviola, G. (2010). Early postnatal behavioral changes in the Mecp2-308 truncation mouse model of Rett syndrome. Genes Brain Behav. 9, 213-223.
36. De Filippis, B., Fabbri, A., Simone, D., Canese, R., Ricceri, L., Malchiodi-Albedi, F., Laviola, G. and Fiorentini, C. (2012). Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome. Neuropsychopharm. 37,1152-1163.
37. Deng, V., Matagne, V., Banine, F., Frerking, M., Ohliger, P., Budden, S., Pevsner, J., Dissen, G. A., Sherman, L. S. and Ojeda, S. R. (2007). FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum. Mol. Genet. 16, 640-650. (Pubitemid 46585665)
38. Deogracias, R., Yazdani, M., Dekkers, M. P., Guy, J., Ionescu, M. C., Vogt, K. E. and Barde, Y. A. (2012). Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. USA 109, 14230-14235.
39. Downs, J., Géranton, S. M., Bebbington, A., Jacoby, P., Bahi-Buisson, N., Ravine, D. and Leonard, H. (2010). Linking MECP2 and pain sensitivity: the example of Rett syndrome. Am. J. Med. Genet. 152A, 1197-1205.
40. Elian, M. and Rudolf, N. D. (1991). EEG and respiration in Rett syndrome. Acta Neurol. Scand. 83, 123-128.
41. Fisher, M., Feuerstein, G., Howells, D. W., Hurn, P. D., Kent, T. A., Savitz, S. I. and Lo, E. H. (2009). Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40, 2244-2250.
42. FitzGerald, P. M., Jankovic, J., Glaze, D. G., Schultz, R. and Percy, A. K. (1990a). Extrapyramidal involvement in Rett's syndrome. Neurology 40, 293-295. (Pubitemid 20099442)
43. FitzGerald, P. M., Jankovic, J. and Percy, A. K. (1990b). Rett syndrome and associated movement disorders. Mov. Disord. 5, 195-202. (Pubitemid 20311768)
44. Gadalla, K. K., Bailey, M. E. and Cobb, S. R. (2011). MeCP2 and Rett syndrome: reversibility and potential avenues for therapy. Biochem. J. 439, 1-14.
45. Gantz, S. C., Ford, C. P., Neve, K. A. and Williams, J. T. (2011). Loss of Mecp2 in substantia nigra dopamine neurons compromises the nigrostriatal pathway. J. Neurosci. 31, 12629-12637.
46. Giacometti, E., Luikenhuis, S., Beard, C. and Jaenisch, R. (2007). Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc. Natl. Acad. Sci. USA 104, 1931-1936. (Pubitemid 46239881)
47. Glaze, D. G. (2005). Neurophysiology of Rett syndrome. J. Child Neurol. 20, 740-746.
48. Glaze, D. G., Schultz, R. J. and Frost, J. D. (1998). Rett syndrome: characterization of seizures versus non-seizures. Electroencephalogr. Clin. Neurophysiol. 106, 79-83. (Pubitemid 28079016)
49. Glaze, D. G., Percy, A. K., Skinner, S., Motil, K. J., Neul, J. L., Barrish, J. O., Lane, J. B., Geerts, S. P., Annese, F., Graham, J. et al. (2010). Epilepsy and the natural history of Rett syndrome. Neurology 74, 909-912.
50. Goffin, D., Allen, M., Zhang, L., Amorim, M., Wang, I. T., Reyes, A. R., Mercado-Berton, A., Ong, C., Cohen, S., Hu, L. et al. (2012). Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat. Neurosci. 15, 274-283.
51. Guideri, F., Acampa, M., Calamandrei, G., Aloe, L., Zappella, M. and Hayek, Y. (2004). Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome. Pediatr. Cardiol. 25, 394-396. (Pubitemid 38989527)
52. Guy, J., Hendrich, B., Holmes, M., Martin, J. E. and Bird, A. (2001). A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27, 322-326. (Pubitemid 32201856)
53. Guy, J., Gan, J., Selfridge, J., Cobb, S. and Bird, A. (2007). Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143-1147. (Pubitemid 46328028)
54. Hagberg, B. (2002). Clinical manifestations and stages of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 8, 61-65.
55. Hagberg, B., Aicardi, J., Dias, K. and Ramos, O. (1983). A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann. Neurol. 14, 471-479. (Pubitemid 13010048)
56. Henderson, C., Wijetunge, L., Kinoshita, M. N., Shumway, M., Hammond, R. S., Postma, F. R., Brynczka, C., Rush, R., Thomas, A., Paylor, R. et al. (2012). Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen. Sci. Transl. Med. 4, 152ra128.
57. Jellinger, K., Armstrong, D., Zoghbi, H. Y. and Percy, A. K. (1988). Neuropathology of Rett syndrome. Acta Neuropathol. 76, 142-158.
58. Jentarra, G. M., Olfers, S. L., Rice, S. G., Srivastava, N., Homanics, G. E., Blue, M., Naidu, S. and Narayanan, V. (2010). Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation. BMC Neurosci. 11, 19.
59. Johnson, R. A., Lam, M., Punzo, A. M., Li, H., Lin, B. R., Ye, K., Mitchell, G. S. and Chang, Q. (2012). 7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome. J. Appl. Physiol. 112, 704-710.
60. Jugloff, D. G., Vandamme, K., Logan, R., Visanji, N. P., Brotchie, J. M. and Eubanks, J. H. (2008). Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice. Hum. Mol. Genet. 17, 1386-1396.
61. Julu, P. O. and Witt Engerström, I. (2005). Assessment of the maturity-related brainstem functions reveals the heterogeneous phenotypes and facilitates clinical management of Rett syndrome. Brain Dev. 27 Suppl. 1, S43-S53. (Pubitemid 41501609)
62. Julu, P. O., Kerr, A. M., Apartopoulos, F., Al-Rawas, S., Engerström, I. W., Engerström, L., Jamal, G. A. and Hansen, S. (2001). Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder. Arch. Dis. Child. 85, 29-37.
63. Kaufmann, W. E., Naidu, S. and Budden, S. (1995). Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome. Neuropediatrics 26, 109-113.
64. Kaufmann, W. E., MacDonald, S. M. and Altamura, C. R. (2000). Dendritic cytoskeletal protein expression in mental retardation: an immunohistochemical study of the neocortex in Rett syndrome. Cereb. Cortex 10, 992-1004.
65. Kaufmann, W. E., Tierney, E., Rohde, C. A., Suarez-Pedraza, M. C., Clarke, M. A., Salorio, C. F., Bibat, G., Bukelis, I., Naram, D., Lanham, D. C. et al. (2012). Social impairments in Rett syndrome: characteristics and relationship with clinical severity. J. Intellect. Disabil. Res. 56, 233-247.
66. Kerr, A. M., Armstrong, D. D., Prescott, R. J., Doyle, D. and Kearney, D. L. (1997). Rett syndrome: analysis of deaths in the British survey. Eur. Child Adolesc. Psychiatry 6 Suppl. 1, 71-74. (Pubitemid 28027156)
67. Kerr, B., Alvarez-Saavedra, M., Sáez, M. A., Saona, A. and Young, J. I. (2008). Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice. Hum. Mol. Genet. 17, 1707-1717. (Pubitemid 351791497)
68. Kerr, B., Soto C, J., Saez, M., Abrams, A., Walz, K. and Young, J. I. (2012). Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes. Eur. J. Hum. Genet. 20, 69-76.
69. Kline, D. D., Ogier, M., Kunze, D. L. and Katz, D. M. (2010). Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice. J. Neurosci. 30, 5303-5310.
70. Kondo, M., Gray, L. J., Pelka, G. J., Christodoulou, J., Tam, P. P. and Hannan, A. J. (2008). Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome - Mecp2 gene dosage effects and BDNF expression. Eur. J. Neurosci. 27, 3342-3350. (Pubitemid 351847324)
71. Kortüm, F., Das, S., Flindt, M., Morris-Rosendahl, D. J., Stefanova, I., Goldstein, A., Horn, D., Klopocki, E., Kluger, G., Martin, P. et al. (2011). The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis. J. Med. Genet. 48, 396-406.
72. Kron, M., Howell, C. J., Adams, I. T., Ransbottom, M., Ogier, M. and Katz, D. M. (2012). Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment. J. Neurosci. 32, 13860-13872.
73. Kudo, S., Nomura, Y., Segawa, M., Fujita, N., Nakao, M., Dragich, J., Schanen, C. and Tamura, M. (2001). Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems. Brain Dev. 23 Suppl. 1, S165-S173.
74. Landis, S. C., Amara, S. G., Asadullah, K., Austin, C. P., Blumenstein, R., Bradley, E. W., Crystal, R. G., Darnell, R. B., Ferrante, R. J., H. Fillit, H. et al. (2012). A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490, 187-191.
75. Lawson-Yuen, A., Liu, D., Han, L., Jiang, Z. I., Tsai, G. E., Basu, A. C., Picker, J., Feng, J. and Coyle, J. T. (2007). Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice. Brain Res. 1180, 1-6. (Pubitemid 350018731)
76. Li, W., Calfa, G., Larimore, J. and Pozzo-Miller, L. (2012). Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice. Proc. Natl. Acad. Sci. USA 109, 17087-17092.
77. +/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder. Neurobiol. Dis. 46, 88-92.
78. Lioy, D. T., Garg, S. K., Monaghan, C. E., Raber, J., Foust, K. D., Kaspar, B. K., Hirrlinger, P. G., Kirchhoff, F., Bissonnette, J. M., Ballas, N. et al. (2011). A role for glia in the progression of Rett's syndrome. Nature 475, 497-500.
79. Lonetti, G., Angelucci, A., Morando, L., Boggio, E. M., Giustetto, M. and Pizzorusso, T. (2010). Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol. Psychiatry 67, 657-665.
80. Luikenhuis, S., Giacometti, E., Beard, C. F. and Jaenisch, R. (2004). Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl. Acad. Sci. USA 101, 6033-6038. (Pubitemid 38520523)
81. Macleod, M. R., O'Collins, T., Horky, L. L., Howells, D. W. and Donnan, G. A. (2005). Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J. Cereb. Blood Flow Metab. 25, 713-721. (Pubitemid 40705606)
82. Marcus, C. L., Carroll, J. L., McColley, S. A., Loughlin, G. M., Curtis, S., Pyzik, P. and Naidu, S. (1994). Polysomnographic characteristics of patients with Rett syndrome. J. Pediatr. 125, 218-224. (Pubitemid 24253001)
83. McCauley, M. D., Wang, T., Mike, E., Herrera, J., Beavers, D. L., Huang, T. W., Ward, C. S., Skinner, S., Percy, A. K., Glaze, D. G. et al. (2011). Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome. Sci. Transl. Med. 3, 113.
84. McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J. and Crawley, J. N. (2008). Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav. 7, 152-163. (Pubitemid 351342192)
85. McGill, B. E., Bundle, S. F., Yaylaoglu, M. B., Carson, J. P., Thaller, C. and Zoghbi, H. Y. (2006). Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. USA 103, 18267-18272. (Pubitemid 44871647)
86. McGraw, C. M., Samaco, R. C. and Zoghbi, H. Y. (2011). Adult neural function requires MeCP2. Science 333, 186.
87. Medrihan, L., Tantalaki, E., Aramuni, G., Sargsyan, V., Dudanova, I., Missler, M. and Zhang, W. (2008). Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J. Neurophysiol. 99, 112-121.
88. Moretti, P., Bouwknecht, J. A., Teague, R., Paylor, R. and Zoghbi, H. Y. (2005). Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum. Mol. Genet. 14, 205-220.
89. Moretti, P., Levenson, J. M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B., Armstrong, D., Arancio, O., Sweatt, J. D. and Zoghbi, H. Y. (2006). Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci. 26, 319-327. (Pubitemid 43089545)
90. Motil, K. J., Schultz, R. J., Browning, K., Trautwein, L. and Glaze, D. G. (1999). Oropharyngeal dysfunction and gastroesophageal dysmotility are present in girls and women with Rett syndrome. J. Pediatr. Gastroenterol. Nutr. 29, 31-37. (Pubitemid 30345824)
91. Motil, K. J., Caeg, E., Barrish, J. O., Geerts, S., Lane, J. B., Percy, A. K., Annese, F., McNair, L., Skinner, S. A., Lee, H. S. et al. (2012). Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with rett syndrome. J. Pediatr. Gastroenterol. Nutr. 55, 292-298.
92. Mount, R. H., Charman, T., Hastings, R. P., Reilly, S. and Cass, H. (2002a). The Rett Syndrome Behaviour Questionnaire (RSBQ): refining the behavioural phenotype of Rett syndrome. J. Child Psychol. Psychiatry 43, 1099-1110. (Pubitemid 36939285)
93. Mount, R. H., Hastings, R. P., Reilly, S., Cass, H. and Charman, T. (2002b). Behaviour problems in adult women with Rett syndrome. J. Intellect. Disabil. Res. 46, 619-624. (Pubitemid 35385862)
94. Mount, R. H., Charman, T., Hastings, R. P., Reilly, S. and Cass, H. (2003). Features of autism in Rett syndrome and severe mental retardation. J. Autism Dev. Disord. 33, 435-442. (Pubitemid 37127939)
95. Nag, N. and Berger-Sweeney, J. E. (2007). Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome. Neurobiol. Dis. 26, 473-480. (Pubitemid 46561344)
96. Nelson, E. D., Kavalali, E. T. and Monteggia, L. M. (2006). MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr. Biol. 16, 710-716.
97. Neul, J. L., Kaufmann, W. E., Glaze, D. G., Christodoulou, J., Clarke, A. J., Bahi-Buisson, N., Leonard, H., Bailey, M. E., Schanen, N. C., Zappella, M. et al. (2010). Rett syndrome: revised diagnostic criteria and nomenclature. Ann. Neurol. 68, 944-950.
98. Nguyen, M. V., Du, F., Felice, C. A., Shan, X., Nigam, A., Mandel, G., Robinson, J. K. and Ballas, N. (2012). MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J. Neurosci. 32, 10021-10034.
99. Ogier, M., Wang, H., Hong, E., Wang, Q., Greenberg, M. E. and Katz, D. M. (2007). Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. J. Neurosci. 27, 10912-10917. (Pubitemid 47535875)
100. Paylor, R. (2009). Questioning standardization in science. Nat. Methods 6, 253-254.
101. Pearson, B. L., Defensor, E. B., Pobbe, R. L., Yamamoto, L. H., Bolivar, V. J., Blanchard, D. C. and Blanchard, R. J. (2012). Mecp2 truncation in male mice promotes affiliative social behavior. Behav. Genet. 42, 299-312.
102. Pelka, G. J., Watson, C. M., Radziewic, T., Hayward, M., Lahooti, H., Christodoulou, J. and Tam, P. P. (2006). Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain 129, 887-898.
103. Percy, A. K., Lee, H. S., Neul, J. L., Lane, J. B., Skinner, S. A., Geerts, S. P., Annese, F., Graham, J., McNair, L., Motil, K. J. et al. (2010). Profiling scoliosis in Rett syndrome. Pediatr. Res. 67, 435-439.
104. Picker, J. D., Yang, R., Ricceri, L. and Berger-Sweeney, J. (2006). An altered neonatal behavioral phenotype in Mecp2 mutant mice. Neuroreport 17, 541-544.
105. Prinz, F., Schlange, T. and Asadullah, K. (2011). Believe it or not: how much can we rely on published data on potential drug targets? Nat. Rev. Drug Discov. 10, 712.
106. Ransohoff, D. F. and Gourlay, M. L. (2010). Sources of bias in specimens for research about molecular markers for cancer. J. Clin. Oncol. 28, 698-704.
107. Reiss, A. L., Faruque, F., Naidu, S., Abrams, M., Beaty, T., Bryan, R. N. and Moser, H. (1993). Neuroanatomy of Rett syndrome: a volumetric imaging study. Ann. Neurol. 34, 227-234. (Pubitemid 23223052)
108. Renieri, A., Mari, F., Mencarelli, M. A., Scala, E., Ariani, F., Longo, I., Meloni, I., Cevenini, G., Pini, G., Hayek, G. et al. (2009). Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant). Brain Dev. 31, 208-216.
109. Robinson, L., Guy, J., McKay, L., Brockett, E., Spike, R. C., Selfridge, J., De Sousa, D., Merusi, C., Riedel, G., Bird, A. et al. (2012). Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. Brain 135, 2699-2710.
110. Rostock, A., Tober, C., Rundfeldt, C., Bartsch, R., Engel, J., Polymeropoulos, E. E., Kutscher, B., Löscher, W., Hönack, D., White, H. S. et al. (1996). D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res. 23, 211-223. (Pubitemid 26176549)
111. Roux, J. C., Dura, E., Moncla, A., Mancini, J. and Villard, L. (2007). Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. Eur. J. Neurosci. 25, 1915-1922. (Pubitemid 46581739)
112. Roux, J. C., Dura, E. and Villard, L. (2008). Tyrosine hydroxylase deficit in the chemoafferent and the sympathoadrenergic pathways of the Mecp2 deficient mouse. Neurosci. Lett. 447, 82-86.
113. Samaco, R. C., Fryer, J. D., Ren, J., Fyffe, S., Chao, H. T., Sun, Y., Greer, J. J., Zoghbi, H. Y. and Neul, J. L. (2008). A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum. Mol. Genet. 17, 1718-1727. (Pubitemid 351791498)
114. +/- mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies. Hum. Mol. Genet. [Epub ahead of print] doi:10.1093/hmg/dds406.
115. Santos, M., Silva-Fernandes, A., Oliveira, P., Sousa, N. and Maciel, P. (2007). Evidence for abnormal early development in a mouse model of Rett syndrome. Genes Brain Behav. 6, 277-286. (Pubitemid 46587988)
116. Schaevitz, L. R., Moriuchi, J. M., Nag, N., Mellot, T. J. and Berger-Sweeney, J. (2010). Cognitive and social functions and growth factors in a mouse model of Rett syndrome. Physiol. Behav. 100, 255-263.
117. Schmid, D. A., Yang, T., Ogier, M., Adams, I., Mirakhur, Y., Wang, Q., Massa, S. M., Longo, F. M. and Katz, D. M. (2012). A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome. J. Neurosci. 32, 1803-1810.
118. Schultz, R. J., Glaze, D. G., Motil, K. J., Armstrong, D. D., del Junco, D. J., Hubbard, C. R. and Percy, A. K. (1993). The pattern of growth failure in Rett syndrome. Am. J. Dis. Child. 147, 633-637. (Pubitemid 23166683)
119. Schulz, K. F., Altman, D. G. and Moher, D. (2010). CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 7, e1000251.
120. Scott, S., Kranz, J. E., Cole, J., Lincecum, J. M., Thompson, K., Kelly, N., Bostrom, A., Theodoss, J., Al-Nakhala, B. M., Vieira, F. G. et al. (2008). Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph. Lateral Scler. 9, 4-15. (Pubitemid 351260367)
121. Sekul, E. A., Moak, J. P., Schultz, R. J., Glaze, D. G., Dunn, J. K. and Percy, A. K. (1994). Electrocardiographic findings in Rett syndrome: an explanation for sudden death? J. Pediatr. 125, 80-82. (Pubitemid 24225185)
122. Sena, E., van der Worp, H. B., Howells, D. and Macleod, M. (2007). How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci. 30, 433-439. (Pubitemid 47374833)
123. Shahbazian, M., Young, J., Yuva-Paylor, L., Spencer, C., Antalffy, B., Noebels, J., Armstrong, D., Paylor, R. and Zoghbi, H. (2002). Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243-254. (Pubitemid 34876728)
124. Shepherd, G. M. and Katz, D. M. (2011). Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and Met. Curr. Opin. Neurobiol. 21, 827-833.
125. Shineman, D. W., Basi, G. S., Bizon, J. L., Colton, C. A., Greenberg, B. D., Hollister, B. A., Lincecum, J., Leblanc, G. G., Lee, L. B., Luo, F. et al. (2011). Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies. Alzheimers Res. Ther. 3, 28.
126. Stearns, N. A., Schaevitz, L. R., Bowling, H., Nag, N., Berger, U. V. and Berger-Sweeney, J. (2007). Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome. Neuroscience 146, 907-921. (Pubitemid 46694130)
127. Stettner, G. M., Huppke, P., Brendel, C., Richter, D. W., Gärtner, J. and Dutschmann, M. (2007). Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-/y knockout mice. J. Physiol. 579, 863-876. (Pubitemid 46404365)
128. Steward, O., Popovich, P. G., Dietrich, W. D. and Kleitman, N. (2012). Replication and reproducibility in spinal cord injury research. Exp. Neurol. 233, 597-605.
129. Stöhr, T., Kupferberg, H. J., Stables, J. P., Choi, D., Harris, R. H., Kohn, H., Walton, N. and White, H. S. (2007). Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy. Epilepsy Res. 74, 147-154. (Pubitemid 46654745)
130. Taneja, P., Ogier, M., Brooks-Harris, G., Schmid, D. A., Katz, D. M. and Nelson, S. B. (2009). Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome. J. Neurosci. 29, 12187-12195.
131. Tarquinio, D., Motil, K., Hou, W., Lee, H., Glaze, D. G., Skinner, S. A., Neul, J. L., Annese, F., McNair, L., Barrish, J. O. et al. (2012). Growth failure and outcome in Rett syndrome: Specific growth references. Neurology 79, 1653-1661.
132. Tropea, D., Giacometti, E., Wilson, N. R., Beard, C., McCurry, C., Fu, D. D., Flannery, R., Jaenisch, R. and Sur, M. (2009). Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc. Natl. Acad. Sci. USA 106, 2029-2034.
133. van der Staay, F. J. and Steckler, T. (2002). The fallacy of behavioral phenotyping without standardisation. Genes Brain Behav. 1, 9-13.
134. Voituron, N., Zanella, S., Menuet, C., Dutschmann, M. and Hilaire, G. (2009). Early breathing defects after moderate hypoxia or hypercapnia in a mouse model of Rett syndrome. Respir. Physiol. Neurobiol. 168, 109-118.
135. Wang, H., Chan, S. A., Ogier, M., Hellard, D., Wang, Q., Smith, C. and Katz, D. M. (2006). Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice. J. Neurosci. 26, 10911-10915.
136. Ward, C. S., Arvide, E. M., Huang, T. W., Yoo, J., Noebels, J. L. and Neul, J. L. (2011). MeCP2 is critical within HoxB1-derived tissues of mice for normal lifespan. J. Neurosci. 31, 10359-10370.
137. Weese-Mayer, D. E., Lieske, S. P., Boothby, C. M., Kenny, A. S., Bennett, H. L., Silvestri, J. M. and Ramirez, J. M. (2006). Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatr. Res. 60, 443-449. (Pubitemid 44427598)
138. Weese-Mayer, D. E., Lieske, S. P., Boothby, C. M., Kenny, A. S., Bennett, H. L. and Ramirez, J. M. (2008). Autonomic dysregulation in young girls with Rett Syndrome during nighttime in-home recordings. Pediatr. Pulmonol. 43, 1045-1060.
139. Wither, R. G., Colic, S., Wu, C., Bardakjian, B. L., Zhang, L. and Eubanks, J. H. (2012). Daily rhythmic behaviors and thermoregulatory patterns are disrupted in adult female MeCP2-deficient mice. PLoS ONE 7, e35396.
140. Zanella, S., Mebarek, S., Lajard, A. M., Picard, N., Dutschmann, M. and Hilaire, G. (2008). Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model. Respir. Physiol. Neurobiol. 160, 116-121. (Pubitemid 350218233)
141. Zhang, L., He, J., Jugloff, D. G. and Eubanks, J. H. (2008). The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus 18, 294-309. (Pubitemid 351399632)